	Prediction of microvascular invasion and post-resection prognosis using ADV, AFP-PIVKA-II, and MoRAL scores in hepatocellular carcinoma patients: an international multicenter cohort study with 9,061 patients. Ann Surg Treat Res Choi M, Hwang S, Kaibori M, Jo M, Collaboration of Korean Association of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery. PMID: 42131421 [PubMed]
	Evaluation of translational potential of mRNA vaccine candidate antigens for pancreatic cancer: a systematic review based on clinical evidence and stratified prioritization strategies. Front Immunol Xue Y, Yu J, Zhou H, Chen W, Chen Q, Hu L, Luo R, Chen Y, Wang X, He X. PMID: 42131338 [PubMed - indexed for MEDLINE]
	MicroRNA-based strategies to overcome the immunotherapy barrier in pancreatic ductal adenocarcinoma. Front Immunol Xu H, Wang Q, Cao R, Qiu Z, Liu Y, Hu J, Zheng G, Cheng C. PMID: 42131318 [PubMed - indexed for MEDLINE]
	Immunosuppressive roles of pericytes in cancer disease: insights from a systematic review and meta-analysis. J Transl Med Hernández-Camarero P, Toledo B, Díaz-Ruano AB, Picon-Ruiz M, González-Titos A, Madeddu R, Marchal JA, Perán M. PMID: 42129871 [PubMed - as supplied by publisher]
	From diagnostic technology to pathway design: what the Onomichi Method teaches us about early pancreatic cancer detection. Pancreatology Yamao K, Kin T, Ohtsuka T. PMID: 42128797 [PubMed - as supplied by publisher]
	Cancer loyalty card study-2 (CLOCS-2): protocol for an observational case-control study focusing on the patient interval in cancer diagnosis. BMJ Open Toopchiani S, Codling S, Pondeca Y, Kaur S, Horeau K, Brewer H, Cross A, Delaney B, Faisal AA, Peters C, Goulding J, Hirst Y, Sundar S, Flanagan JM. PMID: 42128509 [PubMed - indexed for MEDLINE]
	Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10). BMJ Open Ozaki Y, Koyama S, Morita S, Miyashita M, Tokuda E, Shimoi T, Fukuoka M, Masuda H, Takano Y, Shibata N, Yoshinami T, Murakami A, Tamaki K, Ishiguro H, Saji S, Miwa A, Matsunaga J, Zheng Y, Nishikawa H, Masuda N. PMID: 42128502 [PubMed - indexed for MEDLINE]
	Beyond Performance Status: Optimize Cancer Care in Older Adults. Am Soc Clin Oncol Educ Book Lichtman SM. PMID: 42127340 [PubMed - indexed for MEDLINE]
	Tumor Mutational Concordance and Recurrence Timing in Hepatocellular Carcinoma. Hepatol Res Miura Y, Ashida R, Ohshima K, Okamura Y, Nagashima T, Hatakeyama K, Sugiura T, Ohgi K, Otsuka S, Dei H, Kakuda Y, Oishi T, Urakami K, Akiyama Y, Uesaka K, Yamaguchi K. PMID: 42127225 [PubMed - as supplied by publisher]
	Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction-a comprehensive review. Clin Transl Oncol Sethi N, Varma CV, Reddy SS. PMID: 42126789 [PubMed - as supplied by publisher]
	Clinical Presentation and Management Outcomes of Pancreatic Cancer in African Countries: A Scoping Review. J Gastrointest Cancer Gismalla MDA, Elhassan MMA, Abd Elrahman AAEA, Mohamedahmed AY, Saadeldien MSM, Aagla KYKA, Ahmed AMA, Abdelrahim WE, Balakrishnan A. PMID: 42126786 [PubMed - indexed for MEDLINE]
	Association between breast cancer, pancreatic cancer, and melanoma in a CDKN2A variant common in the Hispanic population. Fam Cancer Parkhurst ES, Natoli JL, Wei X, Luna DA, Maarup TJ. PMID: 42126713 [PubMed - indexed for MEDLINE]
	The association between periodontal disease and pancreatic cancer: epidemiology, mechanisms, and implications for clinical management. Front Cell Infect Microbiol Wang B, Cao H, Huang G, Song Y, Ma Y, Gao Z, Li S, Tang Z, Zhang H, Wei W. PMID: 42125497 [PubMed - indexed for MEDLINE]
	Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy. Int J Mol Sci Abou Khouzam R, Salman S, Thiery J, Zaarour RF, Vela V, Limani P, Janji B, Chouaib S. PMID: 42123455 [PubMed - indexed for MEDLINE]
	Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. J Clin Med Terry C, Hall LA, Halle-Smith J, Edwards LA, Sivakumar S, Chapple I, Beggs A, Iqbal T, Roberts KJ. PMID: 42122957 [PubMed]
	Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-Diagnosis. Cancers (Basel) Zhang Z, Carlsson S, Hammar N, Acedo P, Russell B, Kordasti S, Sarker D, Hemelrijck MV, Santaolalla A. PMID: 42122224 [PubMed]
	Therapeutic Cancer Vaccines in Gastrointestinal Malignancies: Advances, Challenges, and Emerging Strategies. Cancers (Basel) Taing K, Dabirian K, Shreenivas A. PMID: 42122214 [PubMed]
	Upfront Chemotherapy Versus Immediate Surgery for Operable Pancreatic Cancer: An Umbrella Review of Meta-Analyses. Cancers (Basel) Ghidini M, Ietto G, Dottorini L, Celotti A, De Giorgi A, Balzano G, Senzani F, Tomasello G, Petrelli F. PMID: 42122141 [PubMed]
	Uric Acid-Driven Biomarkers and Clinical Outcomes in Metastatic Pancreatic Cancer: A Multicenter Real-World Cohort Study. Diagnostics (Basel) Unlu A, Aydin AA, Baser MN, Turan M, Kocer M, Ozturk B, Yildiz M. PMID: 42122000 [PubMed]
	Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy. Cells Albelal D, Rachamala HK, Saha I, Bhattacharya S, Mukhopadhyay D, Babiker HM. PMID: 42121946 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60036

Page 1 of 3002



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy